ONCOLYTICS BIOTECH I

ONC
Delayed Toronto Stock Exchange - 03:59 2022-12-06 pm EST
2.400 CAD -9.09%

Turn to zoom
Prev.2.40000000
Open2.68000000
High2.68000000
Low2.40000000
Volume106 343
Latest news
5d ago
5d ago
5d ago
5d ago
Chart ONCOLYTICS BIOTECH INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance2,822,822,50
Spread/Res.-15%-15%-4,0%
Spread/Supp.13%33%41%
Support2,121,801,70
Financials
Sales 2022 - - -
Net income 2022 -23,7 M -17,4 M -17,4 M
Net Debt 2022 - - -
P/E ratio 2022 -6,00x
Yield 2022 -
Capitalization 142 M 104 M 104 M
Capi. / Sales 2022 -
Capi. / Sales 2023 118x
Nbr of Employees -
Free-Float 98,7%
Company
Oncolytics Biotech Inc. is a biotechnology company. The Company is engaged in developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. It improves the ability of the immune system to fight...
Sector :
Other Biotechnology & Medical Research
Calendar :
2022-12-07 Presentation
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 2,40 CAD
Average target price 7,25 CAD
Spread / Average Target 202%